Navigation Links
Survey finds elevated rates of new asthma among WTC rescue and recovery workers
Date:8/27/2007

Findings released today by the Health Department shed new light on the health effects of exposure to dust and debris among workers who responded to the World Trade Center disaster on September 11, 2001. The data, drawn from the World Trade Center Health Registry, show that 3.6% of the 25,000 rescue and recovery workers enrolled in the Registry report developing asthma after working at the site. That rate is 12 times what would be normally expected for the adult population during such a time period. The paper was published today in the journal Environmental Health Perspectives and is available online at www.ehponline.org.

The rescue and recovery workers are a subset of the 71,000 people enrolled in the registry. The survey, conducted in 2003 and 2004, found that arriving soon after the buildings collapsed, or working on the WTC pile over a long period, increased the workers risk of developing asthma. Workers who arrived on September 11, 2001, and worked more than 90 days reported the highest rate of new asthma (7%).

Though respirator use increased as the clean-up progressed, many workers did not wear respiratory protection at the outset. Certain respirators can reduce exposure to hazardous dust when used correctly, but the survey could not distinguish among different types of masks or respirators, nor could it gauge correct usage. Workers who wore them on September 11th and September 12th reported newly-diagnosed asthma at lower rates (4.0% and 2.9%, respectively) than those who did not (6.3% and 4.5%). The longer the period of not wearing masks or respirators, the greater the risk, the survey found. Workers who went months without respiratory protection reported two to three times more asthma incidence than those who wore respirators from the outset. Though respirators were shown to be protective, all worker groups, including those who reported wearing masks, had elevated levels of newly reported asthma.

The dust from the World Trade Center collapse appears to have had significant respiratory health effects at least for people who worked at the site, said Dr. Thomas R. Frieden, New York City Health Commissioner. These findings reflect the critical importance of getting appropriate respiratory protection to all workers as quickly as possible during a disaster, and making every effort to make sure workers wear them at all times. The events of 9/11 were unprecedented, and with the urgency of rescue operations and the difficulty of prolonged physical exertion with most types of respirators, there are no easy answers, even in retrospect.

Rescue and recovery workers were a diverse group that included firefighters, police officers, construction workers and volunteers, among others. The study found no significant differences among people of different occupations, but workers locations did affect their risk. Those who were caught in the dust cloud or worked on the debris pile reported asthma at higher rates (4.9% and 4.5% respectively), presumably because they inhaled more dust.

Asthma can be controlled with the right care and medications. Inhaled corticosteroids are a very effective treatment for people with frequent symptoms. By learning what triggers asthma and developing a plan to manage it, people can stay healthy for work, school, and other activities. The Health Department has collaborated with clinicians from WTC Centers of Excellence to develop and distribute treatment guidelines for WTC-related respiratory condition. The guidelines are available at http://home2.nyc.gov/html/doh/downloads/pdf/chi/chi25-7.pdf.

Update on Efforts to Learn More about WTC-Related Illness

The World Trade Center Health Registry, the largest public health registry in U.S. history, was launched in 2003 to track the health of people exposed to the collapse of the World Trade Center and those who worked at the WTC site. The registry is a collaborative effort involving the Health Department, the CDCs Agency for Toxic Substances and Disease Registry (ATSDR), with funding from the Federal Emergency Management Agency (FEMA).

The Health Department is now re-surveying all 71,000 registrants to learn more about their current health status. So far, nearly 60% of registrants have responded. The re-survey will help determine whether respiratory and mental health conditions have persisted five to six years after the disaster. Because of its size, the registry can illuminate patterns that would elude individual physicians and provide valuable guidance to affected groups. Previous findings from the WTC Health Registry can be found at http://www.nyc.gov/html/doh/html/wtc/materials.html.

The Health Department is conducting a separate study of respiratory health among registrants, and is analyzing records to see whether the disaster has affected cancer incidence. The Health Department along with the Fire Department, Mount Sinai Medical Center and Bellevue Hospital is also updating last years guidelines for treating adults with WTC-related illness. A similar group of experts is developing guidelines for treating affected children.


'/>"/>

Contact: Geoffrey Cowley
gcowley@health.nyc.gov
212-788-5290
New York City Health Department
Source:Eurekalert

Related biology news :

1. Survey finds silver contamination in North Pacific waters
2. Survey reveals women and doctors arent talking about HPV
3. Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research
4. Center releases new public survey on stem cells
5. First surveys of Tanzanian mountains reveal 160+ animal species, including new & endemic
6. New research finds surveys of larval-stage organisms effective for measuring marine biodiversity
7. Global survey of lizards reveals greater abundance of animals on islands than on mainland ecosystems
8. Current human embryonic stem cell lines contaminated UCSD/Salk team finds
9. Another Look Finds Promising Proteomics Test is Not Biologically Plausible
10. Study finds more than one-third of human genome regulated by RNA
11. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: